{
  "reasoning": "The query \"Mevacor\" is likely seeking information about the drug Mevastatin, its uses, side effects, mechanisms, or research studies involving it.  The weakness of limited depth in abstracts suggests focusing on expanding the query to encompass broader contexts and related concepts for a more comprehensive understanding.",
  "query_goals": [
    "drug efficacy",
    "statin mechanism",
    "lipid profile",
    "cardiovascular disease",
    "mevastatin side effects"
  ],
  "ineffective_terms": [],
  "breadth_expansion": [
    "cholesterol lowering drugs",
    "hmg-coa reductase inhibitors",
    "lipid metabolism",
    "atherosclerosis",
    "clinical trials"
  ],
  "depth_chain": [
    "hyperlipidemia",
    "dyslipidemia",
    "triglycerides",
    "LDL cholesterol",
    "statin therapy"
  ],
  "augmented_query": "cholesterol lowering drugs, hmg-coa reductase inhibitors, hyperlipidemia, dyslipidemia, triglycerides, LDL cholesterol, statin therapy",
  "ndcg": {
    "NDCG@10": 0.0,
    "NDCG@100": 0.34847,
    "NDCG@1000": 0.34847,
    "NDCG@10000": 0.34847
  },
  "map": {
    "MAP@10": 0.0,
    "MAP@100": 0.1015,
    "MAP@1000": 0.1015,
    "MAP@10000": 0.1015
  },
  "recall": {
    "Recall@10": 0.0,
    "Recall@100": 1.0,
    "Recall@1000": 1.0,
    "Recall@10000": 1.0
  },
  "precision": {
    "P@10": 0.0,
    "P@100": 0.04,
    "P@1000": 0.004,
    "P@10000": 0.0004
  },
  "delta": 0.17537,
  "instruction": "expand",
  "query": "Mevacor",
  "query_id": "PLAIN-1621",
  "dataset": "nfcorpus",
  "generator_model": "ollama_chat/gemma2:9b-instruct-q8_0",
  "temperature": 1.0,
  "thought_process": "Looking at the query \"Mevacor\", this makes me think of statins and their role in lowering cholesterol levels, though the user might actually be trying to understand the broader implications of Mevastatin on cardiovascular health or its specific mechanism of action as an HMG-CoA reductase inhibitor. Hmm, not sure yet, but it seems like there's more to explore beyond just the drug itself.\n\nI'm seeing several possibilities here, from the biochemical pathways involved in lipid metabolism to the clinical outcomes of statin therapy. Let me approach this using the expansion technique, which involves applying specific methods like synonym replacement, conceptual expansion, and domain-specific terminology to discover new relevant documents. This should help because it allows us to systematically explore related concepts and terms that might not be immediately apparent from the original query.\n\nFollowing the expansion technique, I should first elucidate the primary objectives and gaps in the original query. The query goals seem to include understanding drug efficacy, statin mechanisms, lipid profiles, cardiovascular disease, and side effects of Mevastatin. This gives me a foundation to expand upon.\n\nNow, considering the breadth expansion, terms like \"cholesterol lowering drugs\", \"hmg-coa reductase inhibitors\", \"lipid metabolism\", \"atherosclerosis\", and \"clinical trials\" start to emerge. These are broader concepts related to Mevastatin but still within the realm of its application and effects. It's interesting to note how \"hmg-coa reductase inhibitors\" directly relates to the mechanism of action of Mevastatin, while \"lipid metabolism\" and \"atherosclerosis\" touch upon the disease processes it aims to mitigate.\n\nMoving on to depth expansion, I find myself focusing on \"hyperlipidemia\" as a crucial topic. Delving deeper into this, terms such as \"dyslipidemia\", \"triglycerides\", \"LDL cholesterol\", and \"statin therapy\" come into play. These terms represent a progression from the general condition of elevated lipid levels in the blood to specific aspects of lipid profiles and the therapeutic approach to managing them.\n\nApplying the technique leads me to discover terms like \"dyslipidemia\" and \"triglycerides\", which are directly related to the lipid profiles affected by Mevastatin. It also reminds me of the importance of \"LDL cholesterol\" in assessing cardiovascular risk, a key area where statins like Mevastatin have a significant impact. My instinct says we should also consider \"statin therapy\" as a broader context, understanding the role of Mevastatin within the larger framework of statin drugs.\n\nThrough this process of applying the expansion technique and exploring related threads, I believe terms such as \"cholesterol lowering drugs\", \"hmg-coa reductase inhibitors\", \"hyperlipidemia\", \"dyslipidemia\", \"triglycerides\", \"LDL cholesterol\", and \"statin therapy\" would be most effective for expanding our understanding of Mevastatin. They capture both the explicit and implicit aspects of what the user is seeking, from the drug's mechanism and effects to its application in managing lipid-related conditions and reducing cardiovascular risk.",
  "though_generator": "openrouter/meta-llama/llama-3.3-70b-instruct"
}